Versant Capital Management’s Haemonetics HAE Stock Holding History

Versant Capital Management’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$144K	Hold	1,363	–	–	0.01%	765
2026 Q2	$102K	Buy	1,363 +810	+146%	+$52K	0.01%	916
2026 Q1	$31.2K	Buy	553 +49	+10%	+$3.19K	﹤0.01%	1545
2025 Q4	$40.4K	Sell	504 -325	-39%	-$21.8K	0.01%	1201
2025 Q3	$40.4K	Buy	829 +567	+216%	+$35.1K	0.01%	1149
2025 Q2	$19.5K	Buy	262 +235	+870%	+$15.6K	﹤0.01%	1553
2025 Q1	$1.72K	Sell	27 -2	-7%	-$136	﹤0.01%	2286
2024 Q4	$2.26K	Buy	29 +22	+314%	+$1.77K	﹤0.01%	2034
2024 Q3	$563	Hold	7	–	–	﹤0.01%	1848
2024 Q2	$579	Hold	7	–	–	﹤0.01%	1772
2024 Q1	$597	Hold	7	–	–	﹤0.01%	1656
2023 Q4	$599	Hold	7	–	–	﹤0.01%	1636
2023 Q3	$627	Sell	7 -5	-42%	-$446	﹤0.01%	1653
2023 Q2	$1.02K	Buy	12 +3	+33%	+$254	﹤0.01%	1594
2023 Q1	$745	Hold	9	–	–	﹤0.01%	1512
2022 Q4	$708	Hold	9	–	–	﹤0.01%	1378
2022 Q3	$1K	Hold	9	–	–	﹤0.01%	1239
2022 Q2	$1K	Hold	9	–	–	﹤0.01%	1260
2022 Q1	$1K	Hold	9	–	–	﹤0.01%	1281
2021 Q4	$0	Hold	9	–	–	﹤0.01%	1504
2021 Q3	$1K	Hold	9	–	–	﹤0.01%	1272
2021 Q2	$1K	Hold	9	–	–	﹤0.01%	1279
2021 Q1	$1K	Hold	9	–	–	﹤0.01%	1363
2020 Q4	$1K	Hold	9	–	–	﹤0.01%	1215
2020 Q3	$0	Hold	9	–	–	﹤0.01%	1381
2020 Q2	$0	Sell	9 -11	-55%	-$1.11K	﹤0.01%	1397
2020 Q1	$1K	Hold	20	–	–	﹤0.01%	1143
2019 Q4	$2K	Hold	20	–	–	﹤0.01%	1137
2019 Q3	$2K	Sell	20 -9	-31%	-$1.14K	﹤0.01%	1163
2019 Q2	$3K	Sell	29 -120	-81%	-$11.8K	﹤0.01%	1097
2019 Q1	$13K	Sell	149 -232	-61%	-$21.1K	0.01%	804
2018 Q4	$38K	Sell	381 -10	-3%	-$1.05K	0.02%	314
2018 Q3	$44K	Sell	391 -42	-10%	-$4.35K	0.02%	321
2018 Q2	$38K	Sell	433 -22	-5%	-$1.86K	0.02%	381
2018 Q1	$33K	Sell	455 -6	-1%	-$412	0.01%	430
2017 Q4	$26K	Buy	461 +139	+43%	+$7.32K	0.01%	536
2017 Q3	$14K	Buy	322 +11	+4%	+$457	0.01%	714
2017 Q2	$12K	Buy	311 +83	+36%	+$3.41K	0.01%	791
2017 Q1	$9K	Sell	228 -7	-3%	-$273	0.01%	874
2016 Q4	$9K	Sell	235 -82	-26%	-$3.09K	0.01%	860
2016 Q3	$11K	Buy	317 +151	+91%	+$5.18K	0.01%	775
2016 Q2	$4K	Sell	166 -101	-38%	-$3.05K	﹤0.01%	1014
2016 Q1	$9K	Sell	267 -11	-4%	-$355	0.01%	788
2015 Q4	$8K	Buy	+278	New	+$9.02K	0.01%	796

Other funds holding HAE

CIM

Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return

CPBTD

Central Pacific Bank - Trust Division Honolulu, Hawaii $952M AUM 25.15% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

Versant Capital Management's HAE Position: Q3 2026 in Review

Versant Capital Management held its Haemonetics (HAE) position steady in Q3 2026 at 1,363 shares worth $144K. The position accounts for 0.01% of the portfolio, ranked #765.

Versant Capital Management first reported a position in HAE in Q4 2015 and has held it in 44 quarters since. 7 funds tracked by Wall St. Rank hold HAE as of Q3 2026.

Versant Capital Management held 1,363 shares of Haemonetics worth $144K as of Q3 2026.
Versant Capital Management left its Haemonetics share count unchanged in Q3 2026.
Haemonetics made up 0.01% of Versant Capital Management's portfolio in Q3 2026, its #765 holding.
Versant Capital Management first reported a position in Haemonetics in Q4 2015 and has held it in 44 quarters since.
7 funds tracked by Wall St. Rank held Haemonetics as of Q3 2026.

Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.